Streetbeat News

Stock Prices

ARGT

BDRY

CYA

RAYS

Micro-cap ETFs, with AUM under $400 million, saw varied performance over the past week. Breakwave Dry Bulk Shipping ETF (BDRY) rose 21.03%, while Global X MSCI Argentina ETF (ARGT) increased by 7.51% following the Argentine election. Conversely, Simplify Tail Risk Strategy ETF (CYA) and Global X Solar ETF (RAYS) fell by 13.52% and 6.40%, respectively. BDRY and ARGT have shown positive year-to-date (YTD) returns, whereas CYA and RAYS have experienced significant declines YTD.

Portfolio Pulse from Johnny Rice

November 28, 2023 | 8:48 pm

BDRX

Shares of Biodexa Pharmaceuticals were halted due to a circuit breaker after a sharp upside move. However, the stock is currently down 19.2%.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 8:46 pm

NVDA

NVIDIA Corporation (NASDAQ:NVDA) is expanding its autonomous driving team in China by hiring for twenty-four positions across Beijing, Shanghai, and Shenzhen. The recruitment aims to design and deploy AI systems for automation and autonomous vehicles, led by Xinzhou Wu, an expert in the Chinese AV market. Despite U.S. export controls on AI GPUs, Nvidia's automotive products remain unaffected. NVDA shares were down 1.21% at $476.61 at the time of publication.

Portfolio Pulse from Ryan Gustafson

November 28, 2023 | 8:43 pm

LOCC

Live Oak Crestview Climate Acquisition Corp. (LOCC) received a notice from NYSE for not filing its Q3 Form 10-Q on time. Despite this, the notice does not affect LOCC's current NYSE listing. However, LOCC will redeem all outstanding shares of Class A common stock and will not be listed on the NYSE after the liquidation effective November 30, 2023.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 8:34 pm

TMO

Thermo Fisher Scientific Inc. (NYSE:TMO) saw a 0.68% drop in its share price to $486.80 in the current market session. Despite a 9.45% increase over the past month, the stock has decreased by 13.11% over the past year. The company's P/E ratio of 32.12 is lower than the industry average of 37.9, which could suggest it is undervalued or expected to underperform compared to its peers in the Life Sciences Tools & Services industry.

Portfolio Pulse from Benzinga Insights

November 28, 2023 | 8:30 pm

LCID

RACE

RIVN

TSLA

BofA Global Research analysts predict significant growth for General Motors Co (GM) with a 165% stock upside and a price target of $75. The optimism is based on GM's well-managed core business and potential in autonomous electric vehicle fleets. Risks include a downturn in U.S. auto sales and rising input costs, among others. Upside risks involve U.S. auto cycle strength and growth in China. Other automakers' stocks like Rivian (RIVN), Ford (F), Lucid (LCID), Ferrari (RACE), and Tesla (TSLA) also have upside potential, but less compared to GM.

Portfolio Pulse from Surbhi Jain

November 28, 2023 | 8:24 pm

EIS

SPY

VGK

U.S. Senate Majority Leader Chuck Schumer announced plans to bring the Israel Ukraine Bill to the Senate floor next week. This legislative move could have implications for U.S. foreign policy and defense-related stocks.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 8:23 pm

SPHR

U2's residency at The Sphere in Las Vegas, titled 'U2:UV Achtung Baby Live at Sphere', has grossed $109.8 million from 17 shows, selling 281,000 tickets. With an average of $6.5 million and 16,500 tickets per show, the average ticket price was $390.97. This residency is the fastest grossing in Boxscore history, with potential to reach $330 million after all scheduled shows. The Sphere, a venue with a $2.3 billion cost, has been highlighted for its advanced audiovisual technology.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 8:18 pm

TSLA

Elon Musk has announced that Tesla will start delivering its Cybertruck on Thursday. This marks the beginning of the much-anticipated electric pickup truck's rollout to customers.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 8:02 pm

IBIO

iBio, Inc. (NASDAQ:IBIO) has announced a 20-to-1 reverse stock split effective November 29, 2023. Shareholders will receive one new share for every 20 old shares, with fractional shares paid out in cash. The reverse split aims to reduce the number of outstanding shares, and adjustments will be made to stock options, warrants, and equity plans. Shareholders with physical stock certificates will receive instructions for exchange, while those with brokerage accounts need not take any action. iBio's 52-week trading range is between $0.20 and $2.60.

Portfolio Pulse from Henry Khederian

November 28, 2023 | 8:01 pm